Epipolythiodiketopiperazine and trichothecene derivatives from the NaI-containing fermentation of marine-derived Trichoderma cf. brevicompactum
- 19 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in The Journal of Antibiotics
- Vol. 73 (8), 559-567
- https://doi.org/10.1038/s41429-020-0314-5
Abstract
The marine-derived fungus Trichoderma sp. TPU199 (cf. Trichoderma brevicompactum) produces pretrichodermamide A (1) and gliovirin (2), which possess a rare type of epipolythiodiketopiperazine (ETP) structure with a disulfide bridge between the α- and β-positions of two amino acid residues. We previously reported that this strain gave the halogenated ETPs, DC1149B (4), DC1149R (6), and iododithiobrevamide (7), when fermented with sodium halides (NaCl, NaBr, and NaI). Further analyses of the metabolites obtained under NaI-containing culture conditions resulted in the isolation of two new ETP derivatives (11 and 12) and three new trichothecene sesquiterpenes (13–15). The structures of 11 and 12, including their absolute configurations, were elucidated based on spectroscopic data for 11 and 12 and comparisons with those for 1 and related compounds, revealing that 11 was an epimer of 1 at the C-5 position and 12 was a trithio-derivative of 11. The structures of 13–15 were established by analyzing their 1D and 2D NMR data. The absolute configurations of 13–15 were assigned by comparing their experimental electronic circular dichroism (ECD) spectra with the calculated ECD spectrum of 13.Keywords
Funding Information
- MEXT | Japan Society for the Promotion of Science (25870660, 16K21310)
- Takeda Science Foundation
This publication has 19 references indexed in Scilit:
- Actinomycetes: still a source of novel antibioticsNatural Product Reports, 2017
- Antibiotics in the clinical pipeline at the end of 2015The Journal of Antibiotics, 2016
- Prospecting for new bacterial metabolites: a glossary of approaches for inducing, activating and upregulating the biosynthesis of bacterial cryptic or silent natural productsNatural Product Reports, 2015
- Natural product and natural product derived drugs in clinical trialsNatural Product Reports, 2014
- Fungal natural products in research and developmentNatural Product Reports, 2014
- Advances in Aspergillus secondary metabolite research in the post-genomic eraNatural Product Reports, 2012
- Microbial metabolites: 45 years of wandering, wondering and discoveringTetrahedron, 2011
- Triggering cryptic natural product biosynthesis in microorganismsOrganic & Biomolecular Chemistry, 2009
- Transformation of an Irregularly Bridged Epidithiodiketopiperazine to Trichodermamide AOrganic Letters, 2006
- The structure of gliovirin, a new antibiotic from Gliocladium virens.The Journal of Antibiotics, 1982